Completed NA INTERVENTIONAL 3-arm
NCT06332365
Evaluating Treatment Efficacy in Oral Lichen Planus: The Role of Salivary Biomarkers (salivaLichen)
Sponsor: Pia Lopez Jornet
Interventions
Acetonide triamcinolone 0.2% +hyaluronicacid 1% Corticoid Acetonide triamcinolone 0.2% Hyaluronic acid 1%
Updated 3 times since 2024 Last updated: Mar 25, 2024 Started: Jan 3, 2022 Primary completion: Dec 15, 2023 Completion: Feb 19, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Oral Lichen Planus and Oral Lichen Planus Related Stress, this trial is completed. The trial is conducted by Pia Lopez Jornet and has accumulated 3 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2024 — Jul 2024 [monthly]
Completed NA
First recorded
Jan 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Pia Lopez Jornet
Data source: Universidad de Murcia
For direct contact, visit the study record on ClinicalTrials.gov .